# Locally Advanced Pancreatic Cancer After Systemic Therapy: Ablative MR-guided Radiotherapy

> **NCT06272162** · NA · NOT_YET_RECRUITING · sponsor: **UMC Utrecht** · enrollment: 150 (estimated)

## Conditions studied

- Locally Advanced Pancreatic Adenocarcinoma

## Interventions

- **RADIATION:** MR guided radiotherapy

## Key facts

- **NCT ID:** NCT06272162
- **Lead sponsor:** UMC Utrecht
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-02
- **Primary completion:** 2030-01
- **Final completion:** 2030-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2024-02-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06272162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06272162, "Locally Advanced Pancreatic Cancer After Systemic Therapy: Ablative MR-guided Radiotherapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06272162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*